Safe Orthopaedics: Half-Year Report on the Liquidity Contract Signed with Invest Securities

Regulatory News:

SAFE ORTHOPAEDICS (Paris:SAFOR) (Euronext: FR0012452746 – SAFOR), a company offering innovative ranges of sterile implants combined with their single-use instruments for back surgery, releases its half-year report on the liquidity contract signed with Invest Securities.

The following assets appeared on the liquidity account as of June 30, 2015:

• 16,306 shares
• €76,485

As a reminder, when implementing on February 10, 2015, the following assets appeared on the liquidity account:

• 0 shares
• €150,000

Next financial release: 1^st half 2015 results on Monday September 28, 2015 (after market close)

About Safe Orthopaedics

Founded in 2010, Safe Orthopaedics is a French medical technology company that develops and markets an innovative range of sterile implants and associated single-use surgical instruments, with the aim of facilitating safer, optimized and lower-cost spinal surgery. By avoiding the reuse of surgical instruments, Safe Orthopaedics reduces the risk of infection, avoids the cumbersome and unreliable logistics of instrument sterilization, and limits hospital costs. Protected by 17 patent families, the Company’s CE-marked and FDA-approved SteriSpine^TM kits are already being marketed in 12 countries, in Europe and the United States. They are being rapidly adopted by surgeons throughout the world, with nearly 1,000 procedures performed in 2014 and 1,143 in the first half of 2015 alone. The Company is based at Eragny-sur-Oise (France), and has 33 employees and a US subsidiary.

For more information, visit: www.SafeOrtho.com

View source version on businesswire.com: http://www.businesswire.com/news/home/20150729006228/en/